Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen M Gown

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2006
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificityHadi Yaziji, Hector Battifora, Todd S Barry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancersStephen Chia, Brian Norris, Caroline Speers, et al.
The American Journal of Surgical Pathology|February 23, 2016
BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic MesotheliomasHarry C Hwang, Shawna Pyott, Stephanie Rodriguez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 19, 2006
Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7Russell Vang, Allen M Gown, Lee-Shu-Fune Wu, et al.
The American Journal of Surgical Pathology|April 27, 2007
p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomasRussell Vang, Allen M Gown, Maryam Farinola, et al.
JAMA|April 29, 2004
HER-2 testing in breast cancer using parallel tissue-based methodsHadi Yaziji, Lynn C Goldstein, Todd S Barry, et al.
The American Journal of Pathology|April 6, 2010
Diagnostic utility of galectin-3 in thyroid cancerConnie G Chiu, Scott S Strugnell, Obi L Griffith, et al.
Human Pathology|December 4, 2012
Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 casesEsther Oliva, Nathanael F Pinheiro, Niall M Heney, et al.
Translational Oncology|December 20, 2020
Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancerEsmeralda C Marginean, Joanna Gotfrit, Horia Marginean, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 18, 2004
Nuclear beta-catenin in mesenchymal tumorsTony L Ng, Allen M Gown, Todd S Barry, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2006
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificityHadi Yaziji, Hector Battifora, Todd S Barry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancersStephen Chia, Brian Norris, Caroline Speers, et al.
The American Journal of Surgical Pathology|February 23, 2016
BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic MesotheliomasHarry C Hwang, Shawna Pyott, Stephanie Rodriguez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 19, 2006
Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7Russell Vang, Allen M Gown, Lee-Shu-Fune Wu, et al.
The American Journal of Surgical Pathology|April 27, 2007
p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomasRussell Vang, Allen M Gown, Maryam Farinola, et al.
JAMA|April 29, 2004
HER-2 testing in breast cancer using parallel tissue-based methodsHadi Yaziji, Lynn C Goldstein, Todd S Barry, et al.
The American Journal of Pathology|April 6, 2010
Diagnostic utility of galectin-3 in thyroid cancerConnie G Chiu, Scott S Strugnell, Obi L Griffith, et al.
Human Pathology|December 4, 2012
Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 casesEsther Oliva, Nathanael F Pinheiro, Niall M Heney, et al.
Translational Oncology|December 20, 2020
Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancerEsmeralda C Marginean, Joanna Gotfrit, Horia Marginean, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 18, 2004
Nuclear beta-catenin in mesenchymal tumorsTony L Ng, Allen M Gown, Todd S Barry, et al.
Pageof 9